Efficacy News and Research

RSS
ImmunoCellular receives Japanese patent allowance for brain cancer technology

ImmunoCellular receives Japanese patent allowance for brain cancer technology

FDA acknowledges receipt of resubmission of Human Genome Sciences’ raxibacumab BLA

FDA acknowledges receipt of resubmission of Human Genome Sciences’ raxibacumab BLA

Abbott announces CE Marking for ARCHITECT HbA1c assay

Abbott announces CE Marking for ARCHITECT HbA1c assay

Inspiration receives FDA clinical hold order for IB1001 phase III studies on hemophilia B

Inspiration receives FDA clinical hold order for IB1001 phase III studies on hemophilia B

Maternal antiviral suppressive therapy may not be as effective as thought

Maternal antiviral suppressive therapy may not be as effective as thought

Enrollment complete in Lux Biosciences Luveniq Phase 3 study for non-infectious uveitis

Enrollment complete in Lux Biosciences Luveniq Phase 3 study for non-infectious uveitis

Positive data from Tonix's sublingual TNX-102 PK study for fibromyalgia

Positive data from Tonix's sublingual TNX-102 PK study for fibromyalgia

Positive interim results from Inspiration's OBI-1 Phase 2/3 study for acquired hemophilia A

Positive interim results from Inspiration's OBI-1 Phase 2/3 study for acquired hemophilia A

Novel treatment for cancer based on protein from HIV-1 virus

Novel treatment for cancer based on protein from HIV-1 virus

Treatment of Schizophrenia receives notice of intention to grant a European patent

Treatment of Schizophrenia receives notice of intention to grant a European patent

JRD receives FDA priority review designation for XARELTO sNDAs to treat PE, DVT

JRD receives FDA priority review designation for XARELTO sNDAs to treat PE, DVT

PsiOxus closes Series B round of equity financing

PsiOxus closes Series B round of equity financing

Ampio announces results from Optina trial on DME

Ampio announces results from Optina trial on DME

AHF calls for reasonable pricing of Gilead’s Quad AIDS drug

AHF calls for reasonable pricing of Gilead’s Quad AIDS drug

Novel biomimetic strategy can dissolve blood clots before they cause serious damage or even death

Novel biomimetic strategy can dissolve blood clots before they cause serious damage or even death

Robert Wood Johnson Foundation, AJPM introduce Childhood Obesity Challenge

Robert Wood Johnson Foundation, AJPM introduce Childhood Obesity Challenge

Scientists use antibody injections to rapidly reverse onset of Type I diabetes in mice

Scientists use antibody injections to rapidly reverse onset of Type I diabetes in mice

Anti-cancer activity of HuCAL antibody revealed by new data from OncoMed

Anti-cancer activity of HuCAL antibody revealed by new data from OncoMed

Intense war against malaria outlined by two studies in The American Journal of Tropical Medicine and Hygiene

Intense war against malaria outlined by two studies in The American Journal of Tropical Medicine and Hygiene

Shingles vaccine may not increase risk of varicella in people with auto-immune diseases

Shingles vaccine may not increase risk of varicella in people with auto-immune diseases

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.